ArticleInvestigative ophthalmology & visual science2025
Whole Genome Analysis of Ocular Pseudomonas aeruginosa Isolates Reveals Genetic Diversity.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Current Recommendations, Antibiotic Resistance, and Emerging Treatments for Gram-Positive Ocular Infections in the United States.Antibiotics (Basel, Switzerland) · 2026Review
- Review
- Genomic insights into antimicrobial resistance in ocular pathogens from India.Communications biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Purpose: Pseudomonas aeruginosa is a versatile pathogen and leading cause of ocular infections. Several large-scale analyses have identified epidemic clones of P. aeruginosa adapted to human infection, but few genomic studies have focused on ocular infection. We sought to determine whether specific clones of P. aeruginosa are associated with ocular infection and to characterize the pool of virulence factors and antibiotic resistance genes present in ocular isolates. Methods: Ninety-two non-duplicate P. aeruginosa isolates from patients with ocular infections were collected in our service. Whole genome sequencing was completed followed by analysis of phylogeny, key virulence factors, and phenotypic and genotypic antibiotic resistance. Results: We found genetic diversity among our isolates, with no predominant clonal group. Analysis of virulence factors showed that the majority of our isolates encode the exotoxin ExoS, in contrast to previous studies in which ocular isolates were predominantly ExoU-positive. We also found a high frequency of mutations in the quorum sensing receptors LasR and RhlR, adding to growing evidence that such mutations are common in multiple types of infection. Finally, we identified two isolates lacking genes for biofilm exopolysaccharide Psl biosynthesis, as well as within-host variation in alginate production. Consistent with the community origins of our isolates, we found a low rate of antibiotic resistance (<7%), with only two multidrug resistant isolates. Conclusions: Our study significantly increases the number of ocular P. aeruginosa genomes available for phylogenomic analyses and reveals that P. aeruginosa ocular infections at our institution are caused by a highly genetically diverse population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.